Scimitar Equity, LLC is an independent equity research firm focused on providing value-added intelligence and insightful investment conclusions on emerging companies demonstrating real progress toward their vision while meeting quarterly expectation.
RegMed Daily, Closing Bell, 1/19/12, highest close in 6 months, stocks struggled to keep gains as VIX falls 4.3% and risk appetite is back
End of Day, Cause and Effect …
EOD Commentary : Describing the old adage, Keep your eyes open, your head down and your ears flapping … When the market … marches higher as has for the last 3 weeks, it’s … not a news event that triggers the pullback … it just appears to come out of … nowhere and of course when you least expect it!!
Closing Bell: The NASDAQ closed UP +18.62 (+0.67%) to 2,788.33. The Dow closed UP 45.03 (+0.36%) to 12,623.98.
Who’s up … at the close and any … whys: Aastrom (ASTM) +$0.18 <+9.14%> to $2.15; Athersys (ATHYX) +$0.02 <+0.96%> to $2.10; BioMimetic (BMTI) +$0.02 <+1.01%> to $2.00; ImmunoCellular (OTC BB: imuc) +$0.09 <+8.11%> to $1.20; NeoStem (Amex: NBS) +$0.079 <+13.62%> to $0.659; Opexa (OPXA) +$0.02 <+1.61%> to $1.01; Osiris (OSIR) +$0.12 <++2.33%> to $5.28; StemCells (STEM) +$0.01 <+1.25%> to $0.81 and Tengion(TNGN) +$0.045 <+7.09%> to $0.68.
**<Small and Moderate Volumes>
Register here to be notified of future Scimitar Equity articles.
